Abstract

To investigate the role of macrophages as a regulator and producer of nerve growth factor (NGF) in the synovial tissue (ST) of osteoarthritis (OA) joints, the gene expression profiles of several inflammatory cytokines in the ST, including synovial macrophages and fibroblasts, of OA mice (STR/Ort) were characterized. Specifically, real-time polymerase chain reaction analysis was used to evaluate the expression of tumor necrosis factor- (TNF-) α, interleukin- (IL-) 1β, IL-6, and NGF in CD11b+ and CD11b– cells isolated from the ST of a murine OA model. The effects of TNF-α, IL-1β, and IL-6 on the expression of NGF in cultured synovial cells were also examined. The expression of TNF-α, IL-1β, IL-6, and NGF in the ST of STR/Ort was higher than that in C57/BL6J mice. Compared to the CD11b– cell fraction, higher expression levels of TNF-α, IL-1β, and IL-6 were detected in the CD11b+ cell fraction, whereas no differences in the expression of NGF were detected between the two cell fractions. Notably, TNF-α upregulated NGF expression in synovial fibroblasts and macrophages and IL-1β upregulated NGF expression in synovial fibroblasts. IL-1β and TNF-α may regulate NGF signaling in OA joints and be suitable therapeutic targets for treating OA pain.

Highlights

  • Osteoarthritis (OA) is characterized by cartilage breakdown, synovial fibrosis, and osteophyte formation

  • To determine whether macrophages in synovial tissue (ST) produce inflammatory cytokines, expression of the genes encoding tumor necrosis factor- (TNF-)α, IL-1β, and IL-6 in CD11b-positive cells isolated from the ST of STR/Ort mice was examined by real-time PCR

  • In the present study investigating the mechanisms underlying the regulation of Nerve growth factor (NGF) and development of OA pain, higher expression of the genes encoding TNF-α, IL-1β, IL-6, and NGF was observed in the ST of an OA STR/Ort mouse model compared to that in C57BL/6J mice

Read more

Summary

Introduction

Osteoarthritis (OA) is characterized by cartilage breakdown, synovial fibrosis, and osteophyte formation. The neutralization of NGF with tanezumab, an anti-NGF monoclonal antibody, has robust analgesic effects on OA pain [8, 10, 11]. Due to these effects, the regulation of NGF has been investigated in several in vitro and in vivo studies [12, 13]. The regulation of NGF has been investigated in several in vitro and in vivo studies [12, 13] Evidence from these studies suggests that the activity of NGF is mediated by inflammatory cytokines. The mechanism regulating NGF expression in synovial tissue (ST) remains unclear

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call